Bitran Jd
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Oncology top 5%
- Lung Cancer Research Studies
Papers in
- Oncology 18
- Lung Cancer Research Studies 7
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 4
-
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- P. C. Hoffman (4 shared papers)Connie Skosey (3 shared papers)Richard A. Larson (2 shared papers)James Lloyd Wade (2 shared papers)JW Vardiman (2 shared papers)MM Le Beau (2 shared papers)Sandy Purl (2 shared papers)MJ Ratain (2 shared papers)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)CA A Cancer Journal for Clinicians (1 paper)JAMA (1 paper)Bone Marrow Transplantation (1 paper)
- Partner nations
- United States
In The Last Decade
Bitran Jd
32 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Hematology 593
- Oncology 422
- Transplantation 38
- Genetics 137
- Public Health, Environmental and Occupational Health 259
Countries citing papers authored by Bitran Jd
This map shows the geographic impact of Bitran Jd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bitran Jd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bitran Jd more than expected).
Fields of papers citing papers by Bitran Jd
This network shows the impact of papers produced by Bitran Jd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bitran Jd. The network helps show where Bitran Jd may publish in the future.
Co-authors
The 25 scholars most cited alongside Bitran Jd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 434 | |
| 2 | 1987 | 214 | |
| 3 | 1987 | 186 | |
| 4 | Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM). | 1980 | 67 |
| 5 | Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer. | 1996 | 55 |
| 6 | Chemotherapy of metastatic non-small cell bronchogenic carcinoma. | 1983 | 53 |
| 7 | High-dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas. | 1990 | 46 |
| 8 | Invasive thymoma treated with cisplatin. | 1981 | 28 |
| 9 | 1998 | 27 | |
| 10 | Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer. | 1995 | 26 |
| 11 | Chemotherapy for stage IV non-small cell lung cancer. | 1990 | 20 |
| 12 | Management of locally advanced and inflammatory carcinoma of the breast. | 1985 | 19 |
| 13 | 1998 | 16 | |
| 14 | Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma. | 1978 | 15 |
| 15 | Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. | 1990 | 14 |
| 16 | Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU. | 1985 | 11 |
| 17 | Acute leukemia during reproductive life: its course, complications and sequelae for fertility. | 1976 | 10 |
| 18 | High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma. | 1989 | 10 |
| 19 | A phase I-II study of high-dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies. | 1990 | 10 |
| 20 | Patients at increased risk for late engraftment after transplantation: a novel method for their identification. | 1990 | 9 |
About Bitran Jd
Bitran Jd is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Genetics and Hepatology, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (7 papers), Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (593 citations), Oncology (422 citations), Transplantation (38 citations), Genetics (137 citations) and Public Health, Environmental and Occupational Health (259 citations). Bitran Jd has collaborated with scholars based in United States. Frequent co-authors include P. C. Hoffman, Connie Skosey, Richard A. Larson, James Lloyd Wade, JW Vardiman, MM Le Beau, Sandy Purl, MJ Ratain, HM Golomb and Richard K. Desser. Their work appears in journals such as Blood, Journal of Clinical Oncology, CA A Cancer Journal for Clinicians, JAMA and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.